• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
A call for randomized controlled trials of antiretroviral therapy for HIV-2 infection in West Africa.呼吁在西非开展针对HIV-2感染的抗逆转录病毒疗法的随机对照试验。
AIDS. 2008 Oct 18;22(16):2069-72; discussion 2073-4. doi: 10.1097/QAD.0b013e32830edd44.
2
Characteristics of HIV-2 and HIV-1/HIV-2 Dually Seropositive Adults in West Africa Presenting for Care and Antiretroviral Therapy: The IeDEA-West Africa HIV-2 Cohort Study.西非寻求治疗和抗逆转录病毒疗法的HIV-2以及HIV-1/HIV-2双重血清阳性成年人的特征：IeDEA-西非HIV-2队列研究
PLoS One. 2013 Jun 18;8(6):e66135. doi: 10.1371/journal.pone.0066135. Print 2013.
3
Drug switching and virologic-based endpoints in trials of antiretroviral drugs for HIV infection.用于HIV感染的抗逆转录病毒药物试验中的换药与基于病毒学的终点指标
AIDS. 2004 Feb 20;18(3):365-70. doi: 10.1097/00002030-200402200-00001.
4
Treatment comparisons in HIV infection: the benefits and limitations of observational cohort studies.HIV感染中的治疗比较：观察性队列研究的益处与局限性
J Antimicrob Chemother. 2001 Apr;47(4):371-5. doi: 10.1093/jac/47.4.371.
5
Methodological issues of non-inferiority trials in HIV-infected patients: a need for consensus?HIV感染患者非劣效性试验的方法学问题：是否需要达成共识？
AIDS. 2008 May 11;22(8):996-7. doi: 10.1097/QAD.0b013e3282ff6490.
6
Antiretroviral therapy and drug resistance in human immunodeficiency virus type 2 infection.人类免疫缺陷病毒 2 型感染中的抗逆转录病毒治疗和耐药性。
Antiviral Res. 2014 Feb;102:70-86. doi: 10.1016/j.antiviral.2013.12.001. Epub 2013 Dec 15.
7
Rapid progression of CD4 cell decline and subsequent response to salvage therapy in HIV-2 infection.
AIDS. 2002 May 24;16(8):1189-91. doi: 10.1097/00002030-200205240-00016.
8
Clinical trials of antiretroviral therapy in developing countries.
Aust N Z J Med. 2000 Feb;30(1):3-4. doi: 10.1111/j.1445-5994.2000.tb01045.x.
9
Antiretroviral therapy for patients with HIV disease.针对感染HIV患者的抗逆转录病毒疗法。
Br J Clin Pharmacol. 1998 Mar;45(3):221-8. doi: 10.1046/j.1365-2125.1998.00673.x.
10
Should we now adopt the HIV-RNA < 50 copy endpoint for clinical trials of antiretroviral-experienced as well as naive patients?对于接受过抗逆转录病毒治疗的患者以及初治患者的临床试验，我们现在是否应该采用HIV-RNA低于50拷贝的终点指标？
AIDS. 2007 Jul 31;21(12):1651-3. doi: 10.1097/QAD.0b013e3282703593.

引用本文的文献

1
The HIV-2 proviral landscape is dominated by defective proviruses.HIV-2 前病毒景观主要由缺陷前病毒主导。
AIDS. 2024 Mar 1;38(3):309-316. doi: 10.1097/QAD.0000000000003776. Epub 2023 Nov 22.
2
HIV-1 integrase resistance associated mutations and the use of dolutegravir in Sub-Saharan Africa: A systematic review and meta-analysis.人类免疫缺陷病毒1型整合酶耐药相关突变及多替拉韦在撒哈拉以南非洲地区的应用：一项系统评价与荟萃分析
PLOS Glob Public Health. 2022 Oct 11;2(10):e0000826. doi: 10.1371/journal.pgph.0000826. eCollection 2022.
3
Future of HIV2 and HIV2 +  1 Infected Patients Treated with Antiretrovirals Followed at the Day Hospital HIV Care Unit from 2011 to 2015.2011 年至 2015 年在日间医院艾滋病毒护理单位接受抗逆转录病毒治疗的 HIV2 和 HIV2 +  1 感染患者的未来。
J Int Assoc Provid AIDS Care. 2022 Jan-Dec;21:23259582221143675. doi: 10.1177/23259582221143675.
4
Evasion of cGAS and TRIM5 defines pandemic HIV.逃避 cGAS 和 TRIM5 定义了大流行的 HIV。
Nat Microbiol. 2022 Nov;7(11):1762-1776. doi: 10.1038/s41564-022-01247-0. Epub 2022 Oct 26.
5
Survival among antiretroviral-experienced HIV-2 patients experiencing virologic failure with drug resistance mutations in Cote d'Ivoire West Africa.在西非科特迪瓦，有抗逆转录病毒治疗经验且出现病毒学失败并伴有耐药突变的HIV-2患者的生存情况。
PLoS One. 2020 Aug 5;15(8):e0236642. doi: 10.1371/journal.pone.0236642. eCollection 2020.
6
[HIV-2 infection in Senegal: virological failures and resistance to antiretroviral drugs (ARVs)].[塞内加尔的HIV-2感染：病毒学失败及对抗逆转录病毒药物（ARVs）的耐药性]
Pan Afr Med J. 2019 Jul 18;33:222. doi: 10.11604/pamj.2019.33.222.15771. eCollection 2019.
7
Drug resistance mutations and viral load in human immunodeficiency virus type 2 and dual HIV-1/HIV-2 infected patients in Ghana.加纳2型人类免疫缺陷病毒及HIV-1/HIV-2双重感染患者的耐药性突变与病毒载量
Medicine (Baltimore). 2019 Feb;98(6):e14313. doi: 10.1097/MD.0000000000014313.
8
Evaluation of Two HIV Rapid Diagnostic Tests in a Context of Strains' Genetic Diversity in Mali.在马里菌株遗传多样性背景下对两种HIV快速诊断检测的评估
AIDS Res Hum Retroviruses. 2019 Feb;35(2):145-149. doi: 10.1089/AID.2017.0296. Epub 2019 Jan 22.
9
p24 revisited: a landscape review of antigen detection for early HIV diagnosis.重新审视 p24：抗原检测在艾滋病早期诊断中的应用综述
AIDS. 2018 Sep 24;32(15):2089-2102. doi: 10.1097/QAD.0000000000001982.
10
A Trial of a Single-tablet Regimen of Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate for the Initial Treatment of Human Immunodeficiency Virus Type 2 Infection in a Resource-limited Setting: 48-Week Results From Senegal, West Africa.在资源有限的环境下，用艾维雷韦、考比司他、恩曲他滨和替诺福韦富马酸酯单片复方制剂治疗人类免疫缺陷病毒 2 型感染的初治方案的试验：来自塞内加尔，西非的 48 周结果。
Clin Infect Dis. 2018 Oct 30;67(10):1588-1594. doi: 10.1093/cid/ciy324.

本文引用的文献

1
Virological and immunological response to HAART regimen containing integrase inhibitors in HIV-2-infected patients.HIV-2感染患者对含整合酶抑制剂的高效抗逆转录病毒治疗方案的病毒学和免疫学反应。
AIDS. 2008 Mar 12;22(5):665-6. doi: 10.1097/QAD.0b013e3282f51203.
2
Inhibition of HIV-2 protease by HIV-1 protease inhibitors in clinical use.临床使用的HIV-1蛋白酶抑制剂对HIV-2蛋白酶的抑制作用。
Chem Biol Drug Des. 2008 Apr;71(4):298-305. doi: 10.1111/j.1747-0285.2008.00647.x. Epub 2008 Feb 28.
3
Comparison of viro-immunological marker changes between HIV-1 and HIV-2-infected patients in France.法国HIV-1和HIV-2感染患者病毒免疫标志物变化的比较。
AIDS. 2008 Feb 19;22(4):457-68. doi: 10.1097/QAD.0b013e3282f4ddfc.
4
In vitro phenotypic susceptibility of human immunodeficiency virus type 2 clinical isolates to protease inhibitors.2型人类免疫缺陷病毒临床分离株对蛋白酶抑制剂的体外表型敏感性
Antimicrob Agents Chemother. 2008 Apr;52(4):1545-8. doi: 10.1128/AAC.01284-07. Epub 2008 Jan 28.
5
Human immunodeficiency virus types 1 and 2 exhibit comparable sensitivities to Zidovudine and other nucleoside analog inhibitors in vitro.人类免疫缺陷病毒1型和2型在体外对齐多夫定和其他核苷类似物抑制剂表现出相似的敏感性。
Antimicrob Agents Chemother. 2008 Jan;52(1):329-32. doi: 10.1128/AAC.01004-07. Epub 2007 Oct 29.
6
Twenty years of prospective molecular epidemiology in Senegal: changes in HIV diversity.塞内加尔二十年的前瞻性分子流行病学研究：HIV多样性的变化
AIDS Res Hum Retroviruses. 2007 Oct;23(10):1189-96. doi: 10.1089/aid.2007.0037.
7
Genetic polymorphisms and resistance mutations of HIV type 2 in antiretroviral-naive patients in Burkina Faso.布基纳法索未接受过抗逆转录病毒治疗的患者中2型艾滋病毒的基因多态性与耐药性突变
AIDS Res Hum Retroviruses. 2007 Aug;23(8):955-64. doi: 10.1089/aid.2007.0034.
8
Antiretroviral drug-resistant HIV-2 infection--a new therapeutic dilemma.抗逆转录病毒药物耐药的HIV-2感染——一个新的治疗困境。
Int J STD AIDS. 2006 Nov;17(11):781-2. doi: 10.1258/095646206778691059.
9
Commentary: decline of HIV-2 prevalence in West Africa: good news or bad news?评论：西非HIV-2流行率下降：是好消息还是坏消息？
Int J Epidemiol. 2006 Oct;35(5):1329-30. doi: 10.1093/ije/dyl156. Epub 2006 Jul 17.
10
Virological and immunological response to Combivir and emergence of drug resistance mutations in a cohort of HIV-2 patients in The Gambia.冈比亚一组HIV-2患者对双汰芝的病毒学和免疫学反应及耐药突变的出现
AIDS. 2006 Jun 26;20(10):1455-8. doi: 10.1097/01.aids.0000233582.64467.8e.

A call for randomized controlled trials of antiretroviral therapy for HIV-2 infection in West Africa.

作者信息

Gottlieb Geoffrey S, Eholié Serge-Paul, Nkengasong John N, Jallow Sabelle, Rowland-Jones Sarah, Whittle Hilton C, Sow Papa Salif

机构信息

Division of Allergy & Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington 98195, USA.

出版信息

AIDS. 2008 Oct 18;22(16):2069-72; discussion 2073-4. doi: 10.1097/QAD.0b013e32830edd44.

DOI:10.1097/QAD.0b013e32830edd44
PMID:18832869
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2635911/
Abstract
摘要